Market revenue in 2023 | USD 409.3 million |
Market revenue in 2030 | USD 857.0 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.63% in 2023. Horizon Databook has segmented the Asia Pacific real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific RWE market is expected to grow at the fastest rate over the forecast period. This can be attributed to factors such as aging population, rising incidence of chronic diseases, increasing rate of hospitalization, large population, and growing affordability.
The Asia Pacific market comprises China, Japan, and India. Major market players contributing to the market growth in the region by entering into partnerships or expanding their product portfolios are Med pace, Cegedim Health data, Parexel International Corporation, IQVIA, IBM, and others.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account